Since both BDNF and n-3 PUFAs levels are known to be altered in diabetes and several other neurological conditions, our current study aims to investigate the effect of PUFAs and their metabolites on BDNF binding towards the receptor, tropomyosin-related kinase-B (TrkB) and its function through molecular docking simulation. This evidence concerns the gene BDNF and diabetes mellitus.